Clinical Trials At Southeast Nebraska Cancer Center
HEMATOLOGIC CANCER
CONNECT MDS/AML – The Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
- To Find Out More Click Here.
MAGNIFY – Phase III Randomized study of lenalidomide (CC-5013) plus rituximab maintenance therapy followed by lenalidomide single-agent maintenance versus rituximab maintenance in subjects with relapsed/refractory follicular, marginal zone or mantle cell lymphoma.
- To Find Out More Click Here.
informCLL- A Disease Registry for Patients with Chronic Lymphocytic Leukemia
- To Find Out More Click Here.
PERSPECTIVE – A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab versus Placebo in Combination with Rituximab in Treatment Naive Subjects with Follicular Lymphoma
- To Find Out More Click Here.
PLEIDES – A Study to Evaluate Subcutaneous Daratumumab in Combination wtih Standard Multiple Myeloma.
- To Find Out More Click Here.
PREAMBLE – Prospective Research Assessment in Multiple Myeloma: An observational Evaluation (PREAMBLE)
- To Find Out More Click Here.
UNITY 205 – A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 (Umbralisib) with or without Bendamustine and TGR-1202 (Umbralisib) alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma
- To Find Out More Click Here.